The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study

Gabor Liposits*, Stine B. Winther, Jesper Ryg, Halla Skuladottir, Sören Möller, Eva Hofsli, Carl Henrik Shah, Laurids Østergaard Poulsen, Åke Berglund, Camilla Qvortrup, Pia Osterlund, Bengt Glimelius, Halfdan Sorbye, Per Pfeiffer

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

21 Downloads (Pure)
OriginalsprogEngelsk
Artikelnummer101632
TidsskriftJournal of Geriatric Oncology
Vol/bind15
Udgave nummer2
Antal sider4
ISSN1879-4068
DOI
StatusUdgivet - mar. 2024

Bibliografisk note

Funding Information:
This investigator-initiated study was partly funded by Taiho Pharmaceuticals, Nordic Group, The Danish Cancer Society (grant number: R269-A15859), Academy of Geriatric Cancer Research (AgeCare), The Swedish Cancer Society and the Region of Southern Denmark.
  • Nordic9-study

    Liposits, G. I. (Ph.d.-studerende), Pfeiffer, P. (Vejleder), Winther, S. B. (Bivejleder), Ryg, J. (Bivejleder) & Skuladottir, H. (Bivejleder)

    01/09/202031/12/2023

    Projekter: ProjektPh.d-projekt

Citationsformater